|
George J. Morrow Joins PBS Biotech® Advisory BoardCamarillo, California, January 9, 2012 – PBS Biotech®, Inc., the leading supplier of novel single-use bioreactors for the biopharmaceutical industry, announced today that George J. Morrow, former Executive Vice President, Global Commercial Operations, Amgen Inc, joined its Advisory Board.“We’re honored to have Mr. Morrow as a member of our Advisory Board,” said Brian Lee, Ph.D., President and Chief Executive Officer, PBS Biotech. “With over 30 years of global commercial business operations experience at top biopharmaceutical firms, George has a broad and distinguished record of success. At this critical stage as we transition to a fully commercialized company, we look forward to benefiting from his expertise in the biotech industry,” he said. “PBS Biotech has developed a novel, single-use bioreactor architecture and product set that holds a great potential to be the game changer for future bio-manufacturing by offering competitive advantage and sustained value. I am looking forward to contributing to the company’s rapid growth, industry adoption and operational success,” Morrow said. Mr. Morrow served as Executive Vice President, Global Commercial Operations of Amgen Inc. from 2003 until 2011, overseeing all Amgen’s commercial activities in over 50 countries during a period of rapid growth with multiple product launches into competitive markets. From 2001 to 2003, he served as Executive Vice President, Worldwide Sales and Marketing. Prior to Amgen, Mr. Morrow had over 20 years of commercial experience at Merck and GlaxoWellcome Inc. He served as President and Chief Executive Officer of GlaxoWellcome Inc. and as Managing Director of GlaxoWellcome U.K., both subsidiaries of GlaxoSmithKline plc. He was Group Vice President for Commercial Operations, Glaxo Inc. from 1993-1996. Mr. Morrow holds a B.S. in chemistry from Southampton College, Long Island University; an M.S. in biochemistry from Bryn Mawr College; and an M.B.A. from Duke University’s Fuqua School of Business. He is a member of the Duke University Fuqua School of Business Advisory Board and Medical Center Board of Visitors. He is also a member of the Board of Directors of Align Technology, a global medical device company, and Human Genome Sciences (NASDAQ: HGSI) a biopharmaceutical firm. Mr. Morrow has served previously on boards for GlaxoWellcome Inc. and Johns Hopkins School of Public Health. About PBS Biotech PBS Biotech, Inc. is a US corporation that designs and manufactures fully scalable and easy to use single-use bioreactors used by global biotechnology organizations. The company has patented innovative industrial designs and advanced software driven control systems that produce low shear cell culture solutions improving operational flexibility and process efficiency, reducing operating costs and accelerating time to market for biotechnology customers. With headquarters in Camarillo, CA., PBS Biotech is a member of the BioProcess Systems Alliance (BPSA). Contact: PBS Biotech, Inc. Lourie Zak, +1-805-482-7272 Chief Financial Officer |
|
|
